Mark J. Rosenblum - Feb 13, 2023 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Exec VP Finance, CFO
Signature
/s/ Mark J. Rosenblum
Stock symbol
SLRX
Transactions as of
Feb 13, 2023
Transactions value $
$0
Form type
4
Date filed
2/15/2023, 03:06 PM
Previous filing
Jan 5, 2023
Next filing
Feb 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Award $0 +6.43K +41.71% $0.00 21.9K Feb 13, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock granted under the Salarius Pharmaceuticals, Inc. 2015 Equity Incentive Plan in lieu of cash for performance bonus. The shares of common stock are subject to a six-month holding period pursuant to the terms of the restricted stock agreement